Bitcoin surges above $75k as Trump spurs U.S. regulatory hopes

Emcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivity gains. Net profit saw a significant 36.2% rise during the period. The company began its five-year plan on a strong footing for FY27. Emcure also completed the acquisition of a minority stake in Gennova Biopharmaceuticals.

India on Friday emphasised that it shares a strong relationship with Italy and underscored the importance of maintaining mutual respect in public discourse, a day after a Congress leader triggered a controversy with his political jibe at Italian Prime Minister Giorgia Meloni. External Affairs Ministry spokesperson Randhir Jaiswal said this at his bi-weekly media briefing…

JNU’s deprivation points: Who stands to gain and how